Additional Details

  • MoblO2 to Maintain Oxygenation

    National Jewish Health
    Denver CO. 80206
    View Details
  • A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

    Clinical Research Site
    Bend OR. 97701
    View Details
  • A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

    Clinical Research Site
    Kissimmee FL. 34746
    View Details
  • A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

    Clinical Research Site
    Louisville KY. 40202
    View Details
  • A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary Fibrosis (PPF)

    USA001
    DuBois PA. 15801
    View Details
  • Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis

    Trial Management Group Inc
    Windsor ON. N8X1T3
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Mayo Clinic Rochester
    Rochester MN. 55905
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Piedmont Atlanta Hospital (PAH)
    Atlanta GA. 30309
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    University of Kentucky - Div. of Pulmonary, Critical Care, and Sleep Medicine
    Lexington KY. 40536
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Layrek Clinical Research
    Tulsa OK. 74133
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    University of North Carolina at Chapel Hill
    Chapel Hill NC. 27514
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Pulmonary Associates of Richmond Inc. (PAR) - West Broad Location
    Richmond VA. 23230-1710
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Baycare Medical Group Primary Care and Rheumatology - Tampa
    Tampa FL. 33614
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Avanza Medical Center
    Pensacola FL. 32503
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Critical Care Pulmonary And Sleep Associates (CCPSA) - West Clinic
    Lakewood CO. 80228
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Clinical Research Specialists, LLC - Kissimmee
    Kissimmee FL. 34746-4654
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Pulmonlx, LLC
    Greensboro NC. 27403
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    NewportNativeMD, Inc.
    Newport Beach CA. 92663-3600
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Renown Regional Medical Center - Center for Advanced Medicine B
    Reno NV. 89502
    View Details
  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Mayo Clinic Jacksonville
    Jacksonville FL. 32224
    View Details